Companies investing in generative AI find that testing and quality assurance are two of the most critical areas for improvement. Here are four strategies for testing LLMs embedded in generative AI ...

Time is of the essence in drug discovery. And while the process is inherently complex and labour-intensive, biotech and pharma researchers continue to develop efficient ways to synthesize, screen and ...

With more than 20% of organizations deploying updates multiple times per day, according to my company's study, the complexity of test authoring has grown significantly. Test authoring is the process ...